| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000007002 |
| Receipt No. | R000007962 |
| Official scientific title of the study | A randomized, double blind, comparative study of vitamin D3 versus placebo in post-stroke rehabilitation patients |
| Date of disclosure of the study information | 2012/01/02 |
| Last modified on | 2017/08/28 (Ver. 11) |
| Basic information | ||
| Official scientific title of the study | A randomized, double blind, comparative study of vitamin D3 versus placebo in post-stroke rehabilitation patients | |
| Title of the study (Brief title) | RCT with vitamin D for post-stroke rehabilitation patients | |
| Region |
|
|
| Condition | ||
| Condition | Stroke | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We will determine if vitamin D3 peroral administration of 2000IU/day for 3 month can enhance effectiveness of poststroke rehabilitation, by conducting a double blind randomized controlled clinical trial. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | FIM gain(8 weeks) |
| Key secondary outcomes | FIM efficiency, Calf circumference(8 weeks),
Grip strength(8 weeks), Brunnstrom recovery stage(8 weeks) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Vitamin D3 (2000IU/day) | |
| Interventions/Control_2 | placebo | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Poststroke patients hospitalized for rehabilitation
2. Obtained informed consent 3. 20 years of age or older 4. Rehabilitation doctors judge that patients require inpatient rehabilitation for 3 months. |
|||
| Key exclusion criteria | 1. Taking vitamin D supplement or 1,25 vitamin D, Calcium
2. History of kidney stone and bone fracture 3. Ingestion of vitamin D capsule orally is impossible 4. Independent walking or total assistance on admission 5. Other difficulties judged by the surgeon in charge |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Ryo Momosaki |
| Organization | The Jikei University School of Medicine |
| Division name | Department of Rehabilitation Medicine |
| Address | 3-25-8 Nishi-shimbashi, Minato-ku |
| TEL | 03-3433-1111 |
| momosakiryo@gmail.com | |
| Public contact | |
| Name of contact person | Mitsuyoshi Urashima |
| Organization | The Jikei University School of Medicine |
| Division name | Division of Molecular Epidemiology |
| Address | 3-25-8 Nishi-shimbashi, Minato-ku |
| TEL | 03-3433-1111 |
| Homepage URL | http://docrd.jp/ |
| urashima@jikei.ac.jp | |
| Sponsor | |
| Institute | The Jikei University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Jikei University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000007962 |